4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-012823
President and COO sold 3,631 shares at $18.04 ($65,501)
- President and COO acquired 3,108 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohlhepp Ryan President and COO | 2026-02-25 | Option exercise 10b5-1 | +3,108 | $3.79 | $11,779 | 213,272 | D |
| Cohlhepp Ryan President and COO | 2026-02-25 | Sale 10b5-1 | −3,108 | $18.04 | $56,067 | 210,164 | D |
| Cohlhepp Ryan President and COO | 2026-02-25 | Sale 10b5-1 | −523 | $18.04 | $9,435 | 209,641 | D |
| Derivatives | |||||||
| Cohlhepp Ryan President and COO | 2026-02-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,108 | 138,226 | D | ||
| Open-market sales · 3,631 sh · avg $18.04 · $65,501 | |||||||
Loading xslF345X05/wk-form4_1772226833.xml…